Rituximab: Appearance of T-cell lymphoma: 2 case reports

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1213, 2008-01, pp. : 31-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alemtuzumab/fludarabine: EBV-associated B-cell lymphoma in patients with peripheral T-cell lymphoma: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1236, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Mercaptopurine: Hepatosplenic T-cell lymphoma: case report

Reactions Weekly, Vol. 1, Iss. 1315, 2010-01 ,pp. : 32-33

Adis International

Access to resources Recommend Favorite

Efalizumab/infliximab: CD8+ cutaneous T cell lymphoma (first report with efalizumab): 2 case reports

Reactions Weekly, Vol. 1, Iss. 1137, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Rituximab: Prolonged B cell depletion: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1221, 2008-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

Alefacept/methotrexate: Persistent CD4+ T-cell depression: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1232, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite